EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline

Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Thổ Nhĩ Kỳ đề xuất làm trung gian liên quan đến Hezbollah

Thổ Nhĩ Kỳ đề xuất làm trung gian liên quan đến Hezbollah

Thế giới
(Baothanhhoa.vn) - Các nguồn tin ngoại giao cho biết Thổ Nhĩ Kỳ đã tiếp cận Mỹ và Lebanon, đề xuất đóng vai trò trung gian nhằm thúc đẩy một thỏa thuận liên quan đến lực lượng Hezbollah. Đây được xem là bước đi mới của Ankara trong nỗ lực gia tăng ảnh hưởng tại khu...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh